Table 2 Clinical characteristics of... | American Society of Hematology

Table 2

Clinical characteristics of patients with DLBCL

Characteristic	Total	Low-risk group, n = 67	High-risk group, n = 65	P
Age, y				.004
Median	58	51	62
Range	16-92	16-92	23-88
Ann Arbor stage				NS
I	22	14	8
II	41	20	21
III	25	15	10
IV	44	18	26
ECOG performance status
0 to 1	85	46	39	NS
2 or more	47	21	26
Lactate dehydrogenase				NS
High	65	31	34
Low	67	36	31
No. of extranodal sites				NS
0 or 1	110	56	54
More than 1	22	11	11
IPI score				NS
0 to 2	87	49	38
3 to 5	45	18	27
aaIPI score				NS
0	38	19	19
1	35	22	13
2	35	16	19
3	24	10	14

Characteristic	Total	Low-risk group, n = 67	High-risk group, n = 65	P
Age, y				.004
Median	58	51	62
Range	16-92	16-92	23-88
Ann Arbor stage				NS
I	22	14	8
II	41	20	21
III	25	15	10
IV	44	18	26
ECOG performance status
0 to 1	85	46	39	NS
2 or more	47	21	26
Lactate dehydrogenase				NS
High	65	31	34
Low	67	36	31
No. of extranodal sites				NS
0 or 1	110	56	54
More than 1	22	11	11
IPI score				NS
0 to 2	87	49	38
3 to 5	45	18	27
aaIPI score				NS
0	38	19	19
1	35	22	13
2	35	16	19
3	24	10	14

Data are numbers of patients except where otherwise defined.

ECOG indicates Eastern Cooperative Oncology Group.